Parkinson s World A transformational project by The Cure Parkinson s Trust

Similar documents
Navigating the Healthcare Innovation Cycle

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group

Digitisation Plan

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

. Faye Goldman. July Contents

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Medicines Manufacturing in the UK 2017

Strategic Plan Public engagement with research

The IET Strategic Framework. Working to engineer a better world

ABHI Response to the Kennedy short study on Valuing Innovation

RESEARCH AND INNOVATION STRATEGY. ANZPAA National Institute of Forensic Science

Making lives better every day. This is UCB

Innovation for Defence Excellence and Security (IDEaS)

What s going on at the MRC

Before I talk through the strategy itself, I want to tell you more about why

WHY ACCOUNTANCY & SOCIAL DESIGN

SHTG primary submission process

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

COMMUNICATIONS POLICY

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2

2. Evidence themes and their importance along the development path

GLOBAL AFFAIRS CANADA: AN APPROACH TO DEVELOPMENT INNOVATION. April 6, 2018

ONR Strategy 2015 to 2020

Our digital future. SEPA online. Facilitating effective engagement. Enabling business excellence. Sharing environmental information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

IATA Proprietary. Checkpoint of the Future. .A Risk-based Approach to. Passenger Screening. ICAO Regional Seminar on Aviation Security May 2012

Technology and Innovation in the NHS Highlands and Islands Enterprise

December Eucomed HTA Position Paper UK support from ABHI

Supporter Development Officer (Garden BirdWatch)

National Coordinated Registry Network (CRN) Think-tank

Higher Education Contribution to Health Science Innovation

Health Innovation Manchester

Cisco Live Healthcare Innovation Roundtable Discussion. Brendan Lovelock: Cisco Brad Davies: Vector Consulting

Our Corporate Strategy Digital

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry

Being a service designer. Ulla Jones Business OP Financial Group

INTEL INNOVATION GENERATION

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use:

DEVELOPING YOUR DIGITAL ROADMAP

Implementation of Systems Medicine across Europe

Vorwerk Thermomix C O N S U L T A N C Y C A S E S T U D Y

Evidence for Effectiveness

Imperial Business Partners

Evolution of Research Consortia Increasing Clinical Focus

Why, How & What Digital Workplace

Creating Successful Public Private Partnerships Examining External Success Factors

TECHNOLOGY MASTER PLAN

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)

FUTURE NOW Securing Digital Success

UN-GGIM Future Trends in Geospatial Information Management 1

EHR Optimization: Why Is Meaningful Use So Difficult?

Community Information and Consultation Meeting 7 th September 2017

Digital Health Startups A FirstWord ExpertViews Dossier Report

Find and create opportunities for social innovation and business growth.

"Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration" Final version

Six steps to measurable design. Matt Bernius Lead Experience Planner. Kristin Youngling Sr. Director, Data Strategy

Impact Case Study Template. Guidance Document

Translational scientist competency profile

NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY

Summary report: Innovation, Sciences and Economic Development Canada s roundtable on advanced robotics and intelligent automation

ACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017

Dissemination and Exploitation under H2020

Project: HELIUM - Health Innovation Experimental Landscape through Policy Improvement -

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

ITR8. We are the agency that converts clever ideas into successful products. Semir Chouabi

MAG GENDER PAY GAP REPORT 2018

Health & Social Care Industrial Innovation

Inquiry into the future of civil. Inquiry into the future of civil society

Digital Health and Introducing Innovative Technologies in the NHS

WG/STAIR. Knut Blind, STAIR Chairman

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

Empowering young people. headspace Strategic Plan

Creativity, Collaboration and Identity. Program for an EHRA presidency. Christophe Leclercq

Office for Nuclear Regulation Strategy

Collaboration Agreement

ASKING STRATEGIC QUESTIONS.org

Digital Health & Wellbeing Ecosystem

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

Getting from Knowledge to Action: Effectively communicating Research & Development value to multiple Stakeholder Groups.

Bhutan: Adapting to Climate Change through Integrated Water Resources Management

STRATEGIC FRAMEWORK Updated August 2017

Launching an Ambassador Board. Presented by Jessica Elkan

Digital Government Experience Centre. Accelerate your digital transformation

PROGRESS IN BUSINESS MODEL TRANSFORMATION

National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs

Society of Petroleum Engineers Applied Technical Workshop Digital Transformation in E&P: What s Next, Ready to Scale-Up? Sponsorship Proposal

FDA Centers of Excellence in Regulatory and Information Sciences

welcome to katapult partners PHONE : (+44) WEB :

What Works Cities Brief: The City Hall Data Gap

The Rework America Task Force and Eleven Large U.S. Employers Launch the Rework America Business Network to Expand and Strengthen America s Workforce

Nature Research portfolio of journals and services. Joffrey Planchard

A review of the role and costs of clinical commissioning groups

Creating a Vision for Health Literacy s Future: The Research Agenda

Information & Communication Technology Strategy

RESEARCH AND INNOVATION STRATEGY

Digital Project Co-ordinator (1 year contract)

Digital Built Britain David Philp Digital Built Britain (DBB): BIM Working Group

Sustainable Society Network+ Research Call

Transcription:

Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication between scientists, clinicians and people living with Parkinson s. There is no doubt in my mind that if there was a single web portal through which these groups could share points of view, understanding, information resources, experience and passion for progress, that this teamwork would unlock the gates to a wealth of new thinking, new ideas and most importantly, pave the way to a spate of breakthrough treatments. Tom Isaacs, Co-founder, The Cure Parkinson s Trust and Parkinson s Movement In May 2016, The October Club selected The Cure Parkinson s Trust (CPT) as the beneficiary for its 2016 charity fundraising dinner held at the Savoy Hotel. On the evening of 12 October 2016, 610,000 was raised to support the creation of Parkinson s World (PW), a global website designed with the primary aim of transforming the discovery of a cure, or cures, for Parkinson s disease. We are incredibly grateful for this generous donation of funds. The purpose of this PW Interim Report is to update The October Club on PW planning activities to date, including an outline of PW s 2017-2020 and Phase 1 strategy and to provide assurance that great progress is being made and these funds are being invested wisely. In summary, and following significant engagement with each of the four potential PW User Groups during Q1 of 2017, the following PW value proposition has been defined to reflect the unmet need that PW will seek to address, and the unique value the site will strive to offer: PW is a global initiative with the aim of accelerating the discovery of breakthroughs and a cure(s) for Parkinson s. A symptoms-driven, innovative technology solution, with clear, engaging, valuable and validated content, created by and for people with Parkinson s (PwPs) to: promote global collaboration between PwPs, PwP Significant Others, Healthcare Professionals (HCPs) and Researchers (collectively referred to as PW User Groups); and create a global environment of research-readiness, defined as any activities that promote research within or across PW User Groups by all PW User Groups, with the primary aim of encouraging PwPs to engage and participate in appropriate global research. The objectives that flow from the value proposition above enable PW problem statements, and potential solutions, to be rigorously explored with razor-sharp focus and efficiency, ensuring that funding is appropriately allocated, resources are appropriately deployed and the return on investment to and for each global PW User Group is optimised within the earliest possible timeframe. 1

PW Charter A Phase 1 PW Charter has been approved by the PW Steering Committee and presented to the CPT Board of Trustees. This document describes PW s mission and values and Phase 1 key objectives, milestones, risks and risk management. It also outlines the governance structure for the PW project to ensure appropriate levels of oversight for each phase of the development. As a minimum requirement, a monthly update is provided to the PW Steering Committee and approved by the CPT Board of Trustees (quarterly). As set out in the 18 March 2016 CPT Proposal, the funds raised have enabled the recruitment of a PW Program Director and PW Program Coordinator to work with the PW Program Sponsor to: shape the PW vision and strategy; develop a proof of concept/value proposition (i.e. what, where, when, why and for whom); build and test a working prototype; and create a robust 2018-2020 Business Case to demonstrate financial sustainability. A further consideration is the legal structure PW is to adopt to optimise global partnerships with PW User Groups and facilitate engagement with commercial stakeholders from a tax and trading perspective. This will be determined by the end of Phase 1. 2

PW Strategy Phased Approach The PW project has been split into 4 phases with each phase incorporating additional functionality, content and value to each PW User Group, all of which has been methodically incorporated into the PW Project Plan and PW Product Roadmap: Phase 1: develop a proof of concept, reflecting a sample of global PW User Groups (see below), build and test a working prototype and create a robust 2018-2020 Business Case to demonstrate financial sustainability; Phase 2: Soft (Beta) Launch, extend the test group to incorporate a larger sample of global PW User Groups; Phase 3: Hard Launch, with prototype being made publicly available; and Phase 4: Business as Usual (BaU). The timing of each phase is to be confirmed with the aim for Phase 1 activities being completed, including a working prototype, to be showcased at Rallying to the Challenge at the Van Andel Institute in Grand Rapids, Michigan on 28 September 2017. Design Thinking Design thinking is a human-centered approach to innovation that draws from the designer's toolkit to integrate the needs of people, the possibilities of technology, and the requirements for success. Tim Brown, president and CEO, IDEO Design Thinking is an iterative process which seeks to understand users, challenge assumptions and redefine problems to create solutions, in the form of products and services, that puts users at the heart of the innovation process. It is an approach that promotes experimentation, prototyping and testing to ensure that the needs of its users are fully met. Key steps, which have been incorporated into our activities, are illustrated below: 3

PW User Groups Following the principles of good Design Thinking, the PW team has engaged in a significant number of focus groups and interviews with PW User Groups to help understand and explore the problems PW is aiming solve, together with generating ideas around potentially innovative solutions. We will continue to engage with PW User Groups to ensure that PW is co-created and tested by and creating value for, the users it seeks to serve. The following global PW User Groups have been identified as PW s core audience: 1. PwPs - Parkinson s patients are at the heart of the PW initiative in the form of co-creation, testing and the provision of skills, support and expertise throughout the PW project. They are also our primary users of the PW website. 2. PwP Significant Others - this group includes the PwP community of partners, family, friends and carers. They will also be primary users of the PW website. 3. HCPs - this group includes Allied Healthcare Professionals to include PD nurses, physios, occupational therapists, speech and language therapists, nutritionists, PD Consultants, GPs, Movement Disorder Specialists and Neurologists. We will be working with ParkinsonNet, led by Professor Bastiaan Bloem, to develop this offering. 4. Researchers - this group includes basic, pre-clinical and clinical researchers; researchers into Parkinson s symptoms; and researchers engaged in the adoption of Parkinson s related technology and medical devices. We will be working with IOS Press (publishers of the Journal of Parkinson s Disease), and its editor in chief, Professor Patrik Brundin, including other individuals and organisations (to be confirmed), to develop this offering. As set out in the 18 March 2016 CPT Proposal, The October Club funds are limited to developing the patient element of the PW initiative, to include PW User Groups 1 and 2 above. PW User Groups 3 and 4, and the relating value propositions, are being developed with third parties during Phase 1; the success and legal structure of which will be incorporated into the PW 2018-2020 Business Case and Phase 2 PW Charter. PwP problem to be solved Putting PwP at the heart of our proposition, findings to date have generated many thoughtful insights around the issue of research-readiness, including: 4

PW Workstreams Throughout the planning stage, the PW value proposition has been developed to address perceived gaps in the Parkinson s landscape. This has enabled the development of a framework upon which to organise activities and objectives, focused around the following themes, which have been incorporated into the PW Project Plan and PW Product Roadmap: Global Reach - to enhance collaboration across and between global PW User Groups; PD Symptoms-focused - to promote the linking of PwP motor and non-motor symptoms to both drug and non-drug clinical trials and research; Technology and Data - to ensure that emerging technologies, as appropriate, are incorporated to optimise data management and provide a smooth PW User Group experience when engaging with PW; and PW User Groups - to promote research-readiness across and between each PW User Groups. PwP-paired working For Phase 1, each work stream has been given a Lead, with clear Objectives and Milestones (with the intention of repeating this approach for each of PW s phases). In alignment with CPT s strategy to include PwP in all aspects of work delivery, the PW initiative has incorporated PwP-paired working, pairing PwP with colleagues without Parkinson s, to facilitate the inclusion of talented and skilled PwPs in the engagement and delivery of PW activities. CPT plans to develop best practice guidelines to encourage, promote and facilitate organisations to develop PwP inclusivity policies and practices within the workforce. 5

Funding It is anticipated that The October Club funds will enable PW to complete both Phase 1 and Phase 2 activities. A key deliverable for the end of September 2017, in addition to a prototype, is a fully costed 2018-2020 Business Plan. This will enable CPT to determine the funding required to take PW from Phase 2 through to Phase 4 and ensure PW remains a sustainable offering. Reflections on progress 6

We wrote our vision for Parkinson s World a year ago. It has been hugely gratifying to meet each of our proposed PW User Groups and discuss the project with them a year on, and to know that our original vision is not only incredibly necessary, but will make a huge difference to Parkinson s and CPT s clearly defined vision to find cures. The October Club is enabling us to unify Parkinson s in an inspirational and innovative way, for which, very many thanks. - Helen Matthews, CPT COO and PW Program Sponsor. It was fascinating to hear the challenges people with Parkinson s have in accessing information about research. If we can deliver this through Parkinson s World we will have reached a core objective. - Leah Mursaleen, CPT Involvement and Research Officer and PW Program Coordinator and Various Workstreams Lead. It is a real pleasure and privilege to be part of such a talented team in the development and delivery of an innovative and global approach to supporting the PD community. Our journey so far has been busy, productive and insightful. We hope that if PW can go some way to addressing the problems and challenges identified so far, that PW will be a significant contributor to the global discovery of a cure. Elaine Finn, PW Program Director. I am sometimes asked why patients should be involved in the expert work of researchers and scientists. Put simply, it s because patients are also experts in their symptoms because they are forced to live with the consequences of their condition. As such, they can bring knowledge and insights to researchers which would otherwise be unavailable. Thus, the research process becomes co-productive. - David Murray, CPT Trustee and Chair of the PW Steering Committee. Next Steps Tom Isaacs will be providing a brief update at The October Club event at the House of Commons on 3 July 2017. We will also report back on Phase 1 activities and the status of Phase 2 activities and future sources of funding at the end of 2017. 7